Загрузка...
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3788575/ https://ncbi.nlm.nih.gov/pubmed/23912944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3480 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|